查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
角化病蜂群治療市場——增長、未來展望、競爭分析，2023-2031 年
市場調查報告書
商品編碼
1255966

角化病蜂群治療市場——增長、未來展望、競爭分析，2023-2031 年

Porokeratosis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

在 2023 年至 2031 年的預測期內，角化病角化病治療市場預計將以 7% 的複合年增長率增長。 許多因素繼續促進全球市場的擴張，包括腎移植病例的增加、發達國家報銷政策的改善、研究經費的增加以及市場進入者之間的競爭加劇。 角化病角化病治療市場受到多種因素的推動，例如醫療保健專業人員和患者患病率的上升。 水螅角化病患病率上升是推動這種疾病治療市場的一個主要因素。 角化病雖然是一種罕見病，但由於紫外線照射增加、免疫抑製劑使用增加等因素，近年來其發病率有所上升。

此外，醫療專業人員和患者對角化病角化病認識的不斷提高，以及由此產生的對有效治療的需求，也在推動角化病角化病治療市場的發展。 隨著越來越多的人被診斷出患有角化病，越來越需要有關這種疾病及其治療的信息和教育。 因此，對改善角化病症狀和提高生活質量 (QOL) 的治療和療法的需求不斷增加。 此外，皮膚病學的技術進步正在推動市場。 此外，開發新的更有效的角化病療法和角化病療法將推動對這些產品的需求。 這包括開發新的局部和全身療法以及光動力和激光療法等新技術。 不斷上漲的醫療成本也在推動市場。 隨著對角化病角化病認識的提高和新療法的出現，患者更願意投資角化病角化病治療。 因此，尋求角化病治療的患者數量不斷增加，醫療費用也相應增加。

播散性淺表光化性角化病的患病率增加

角化病角化病是一種罕見的皮膚病，影響了近 200,000 名美國人。 角化病最常見的形式是分佈光化性角化病（DSAP）。 據報導，DSAP 的患病率為 23% 至 61.1%，發生率為 12.6% 至 43.4%。 由於這種高患病率和發病率，DSAP 是美國最常治療的疾病。 Mibelli 角化病是下一個最常見的。 角化病 hidra 是一種癌前病變，可能會癌變。 在 6.9% 至 30% 的報告病例中，角化角化病進展為非黑色素瘤皮膚癌。 根據一項研究，大約 8% 的米貝利角化病患者會患上皮膚癌。 此外，在西班牙，10.68%（中位年齡 3.5 歲）的腎移植受者出現角化水腫（1 個系列）。

美容產品需求上升

所提供治療的好處是改善美觀、性能和去除致畸病變。 角化病 角化病的治療高度取決於傷口大小、位置、患者的審美偏好、是否進行治療以及傷口外觀等因素。 由於收入的增加和美容知識的提高和擴展，對角化水腫治療的需求正在增加。 因此，越來越多的消費者將角化病治療視為過上更健康生活方式的必要工具。 由於易於獲得和易於使用，對外部製劑的需求很高。 由於成本高，激光治療在富人中很受歡迎。 它不需要切口或住院的事實也促進了它的流行，使其成為更受歡迎的海德拉角化病治療方法。

治療期間報告的副作用

激光治療的副作用包括輕度紅斑、輕微色素沉著和現代水腫。 根據 dermentz.org 的說法，沒有經過證實的長期治療方法，增加了患者的不情願。 高昂的治療費用和缺乏皮膚治療知識也是抑制角化病治療發展的因素。

邁向快速增長的激光治療市場

日光性角化病通常採用激光治療。 醫生使用激光設備破壞皮膚區域，以便新皮膚可以在其位置生長。 根據 Amarateedha Prak LeCourt 的一篇文章，用激光治療各種類型角化病的患者都取得了良好的效果。 例如，一名患有線狀角化病的患者在用 585 nm 閃光燈泵浦脈衝眼激光照射後表現出改善。 激光治療對 DSAP 患者也有效。 由於激光治療沒有風險，沒有停工期，也沒有因色素沉著或紋理變化而導致的發病率，因此它的引入可能有助於擴大角化病的角化病治療。

醫院在最終用戶市場中佔據壓倒性份額

醫院代表了角化病治療的重要市場機會。 該醫院是角化病診斷和治療的領先中心，提供全面的服務，包括診斷測試、醫療和手術治療以及後續護理。 對於醫院來說，這將帶來更多的收入機會。 通過利用角化病治療的最新技術和發展，醫院可以改善患者的治療效果並吸引更多患者。 這使醫院能夠滿足日益增長的有效角化病角化病治療需求。

北美仍然是世界領先者

北美角化病治療市場的增長受到該病患病率上升、醫療保健專業人員和患者意識提高以及新療法和療法可用性等因素的影響。 由於 DSAP 的流行和腎移植的數量不斷增加，預計該市場將由北美主導。 據 sciencedirect.com 報導，角化病的發病率隨著腎移植患者的增多而增加。

加大研發投入，擴大市場份額

角化病治療藥物的生產商正在採取各種擴張戰略來擴大其在全球蛋白質市場的市場份額。 隨著角化病角化病治療資金的增加，各大公司都在積極投資更好、更有效的角化病角化病治療方法。 主要參與者正在投資開發和推出具有成本效益的優質產品，尤其是在美容消費仍然相對較低的新興市場。 由於角化病角化病治療的資金增加以及產品發布的相關增加，主要參與者之間的競爭正在加劇。

內容

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要產品
  • 市場細分
  • 調查方法
    • 第一階段 - 二次調查
    • 第二階段 - 初步調查
    • 第三階段 - 專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

  • 市場概況：全球角化過度治療市場
  • 全球角化過度治療市場：按類型分類，2022 年
  • 全球角化過度治療市場：2022 年診斷
  • 全球角化過度治療市場：2022 年按治療分類
  • 全球角化過度治療市場：按最終用戶分類，2022 年
  • 全球角化過度治療市場：按地區劃分，2022 年
  • 有吸引力的投資建議：按地區劃分，2022 年

第 3 章角化病角化病治療市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採用的策略
  • 主要產業戰略
  • 等級分析：2022 年與 2031 年

第 4 章角化病角化病治療市場：宏觀分析和市場動態

  • 簡介
  • 2021-2031 年全球角化病角化病治療市場價值
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章角化病角化病治療市場：按類型分類，2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 播散性淺表光化性角化病
    • 播散性淺表角化病
    • 米貝利角化病
    • 可注射線狀角化病
    • 發疹性播散性角化病
    • 掌蹠膿皰病、播散性膿皰病
    • 穿孔角化病
    • 角化病角化病
    • 陰囊角化症
    • 毛囊角化病

第 6 章角化病角化病治療市場：按診斷 2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 活檢
    • 鑑別診斷
      • 鱗狀細胞癌
      • 地衣角化病
      • 表皮痣
    • 其他

第 7 章角化病角化病治療市場：按治療 2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 局部療法
      • 外用 5-氟尿嘧啶
      • 外用咪奎莫特
      • 外用維甲酸
      • 外用維生素 D 類似物
      • 聯合療法
    • 全身治療
      • 口服維甲酸
    • 物理干預
      • 冷凍療法
      • 電絕育和刮宮術
      • 手術切除
      • 磨皮術
    • 激光治療
      • 二氧化碳激光
      • 調Q紅寶石激光器
      • Nd: YAG 激光
      • 脈衝染料激光治療

第 8 章 Keratopore 治療市場：按最終用戶分類，2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 醫院
    • 醫務室
    • 藥房和藥店
    • 診斷中心
    • 研究和學術機構
    • 其他

第 9 章北美角化病精子治療市場 2021-2031

  • 市場概覽
  • 角化角化病治療市場：按類型劃分，2021-2031 年
  • 角化角化病治療市場：按診斷分類，2021-2031 年
  • 角化角化病治療市場：按治療分類，2021-2031 年
  • 角化角化病治療市場：按最終用戶劃分，2021-2031 年
  • 角化角化病治療市場：按地區劃分，2021-2031 年
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 10 章英國和歐盟角化病精子治療市場 2021-2031

  • 市場概覽
  • 角化角化病治療市場：按類型劃分，2021-2031 年
  • 角化角化病治療市場：按診斷分類，2021-2031 年
  • 角化角化病治療市場：按治療分類，2021-2031 年
  • 角化角化病治療市場：按最終用戶劃分，2021-2031 年
  • 角化角化病治療市場：按地區劃分，2021-2031 年
    • 英國/歐盟
      • 英國
      • 做它是
      • 西班牙
      • 意大利
      • 法國
      • 其他歐洲地區

第 11 章亞太角化過度治療市場 2021-2031

  • 市場概覽
  • 角化角化病治療市場：按類型劃分，2021-2031 年
  • 角化角化病治療市場：按診斷分類，2021-2031 年
  • 角化角化病治療市場：按治療分類，2021-2031 年
  • 角化角化病治療市場：按最終用戶劃分，2021-2031 年
  • 角化角化病治療市場：按地區劃分，2021-2031 年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第 12 章拉丁美洲角化病精子治療市場 2021-2031

  • 市場概覽
  • 角化角化病治療市場：按類型劃分，2021-2031 年
  • 角化角化病治療市場：按診斷分類，2021-2031 年
  • 角化角化病治療市場：按治療分類，2021-2031 年
  • 角化角化病治療市場：按最終用戶劃分，2021-2031 年
  • 角化角化病治療市場：按地區劃分，2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第 13 章中東和非洲角化病角化病治療市場 2021-2031

  • 市場概覽
  • 角化角化病治療市場：按類型劃分，2021-2031 年
  • 角化角化病治療市場：按診斷分類，2021-2031 年
  • 角化角化病治療市場：按治療分類，2021-2031 年
  • 角化角化病治療市場：按最終用戶劃分，2021-2031 年
  • 角化角化病治療市場：按地區劃分，2021-2031 年
    • 中東和非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東和非洲地區

第14章公司簡介

  • Coherent Inc.
  • Alma Lasers
  • Almirall
  • Allergan
  • Pfizer
  • Lumenis
  • Coty Inc.
  • Cutera
  • Bioness Inc.
  • Biogen
  • PhotoMedex Inc.
  • Valeant Pharmaceuticals
  • Hologic Inc.
  • IPG Photonics Corporation
  • IRIDEX Corp.
  • 其他
Product Code: 139509-04-23

The market for Porokeratosis Treatment is projected to expand at a CAGR of 7% during the forecast period of 2023 to 2031. Numerous factors, including an increase in renal transplant cases, improved reimbursement policies in developed nations, an increase in research funding, and intensifying competition among market participants, continue to contribute to the expansion of the global market. The porokeratosis treatment market is driven by a number of factors, such as the rising prevalence of the condition among healthcare professionals and patients. The rising prevalence of porokeratosis is a major factor driving the market for treatments for this condition. Porokeratosis is a rare disorder, but its incidence has increased in recent years due to factors such as increased UV radiation exposure and increased use of immunosuppressive drugs.

The growing awareness of porokeratosis among healthcare professionals and patients, resulting in an increasing demand for effective treatments for the condition, is also driving the market for porokeratosis treatments. As more individuals are diagnosed with porokeratosis, there is a growing need for information and education regarding the condition and its treatment. This is resulting in an increased demand for treatments and therapies that can help manage the symptoms of porokeratosis and improve the quality of life for those who have the condition. In addition, technological advancements in dermatology are driving the market. In addition, the development of new, more effective therapies and treatments for porokeratosis drives demand these products. This includes the development of new topical and systemic therapies, as well as new technologies such as photodynamic therapy and laser therapy. Increasing healthcare expenditures are also a market driver. Patients are more willing to invest in the treatment of porokeratosis due to growing awareness of the condition and the availability of new treatments. This is causing an increase in the number of patients seeking treatment for porokeratosis, as well as a corresponding rise in healthcare expenditures.

Increasing Prevalence of Superficial Disseminated Actinic Porokeratosis

Porokeratosis is a rare skin condition that affects fewer than two hundred thousand Americans. The most prevalent form of porokeratosis is the distribution of actinic porokeratosis (DSAP). The reported prevalence of DSAP ranges from 23% to 61.1%, whereas the reported incidence ranges from 12.6% to 43.4% annually. Due to these high prevalence and incidence rates, DSAP is the most frequently treated disorder in the United States. Mibelli The second most common type of porokeratosis is porokeratosis. Porokeratosis is a precancerous lesion that can transform into a cancerous growth. In 6.9% to 30% of reported cases, Pokerokeratosis progressed to non-melanoma skin cancer. About 8% of those affected by Mibelli's porokeratosis develop skin cancer, according to one study. With a median age of 3.5 years, 10.68% of kidney transplant patients in Spain developed porokeratosis in a single series.

As the incidence of porokeratosis in patients who have undergone a renal transplant rises, the market will be bolstered. In 2017, 10.68% of renal transplant recipients in the United States suffered from porokeratosis, according to a report. DSAP is a form of porokeratosis that primarily affects the forearms and legs as a result of excessive sun exposure. Almost 43.4% of women between 30 and 50 years old are diagnosed with DSAP, which is twice as prevalent in women as in men. There is a risk of developing squamous cell carcinomas at the affected site of the body in cases where DSAP is harmful.

There are numerous creams and gels for preventing infection, thereby expanding the market for treatment adoption. It is a rare disease that affects nearly 200,000 people in the United States. According to a publication by the National Library of Medicine, Diclofenac 3% gel is a potential treatment for DSAP, thereby increasing its use.

Increasing Demand for Aesthetic Products

The benefits of the provided treatment improved the aesthetic appearance, performance, and removal of the malformed lesions. The porokeratosis treatment is highly dependent on factors such as the size of the wound, its location, the patient's aesthetic preferences, the availability of treatment, and the appearance of the wound. The demand for porokeratosis treatment has increased as a result of rising income and improved and expanded knowledge of aesthetics. Consequently, consumers increasingly view porokeratosis treatment as a necessary tool for leading a healthier lifestyle. The topical products are in high demand due to their accessibility and ease of use. Due to its high price, laser therapy is popular among affluent consumers. No incision or hospitalization is required, which contributes to its popularity and makes it a more popular therapy for the treatment of porokeratosis.

Consumers are increasingly concerned with aesthetics, particularly in developed nations where disposable income and reimbursement regulations are increasing. Consumers in developed nations are becoming aware of the disease's malignant transformation. The market for porokeratosis will expand as the demand for personal care increases. There is sufficient clinical surveillance to comprehend porokeratosis' malignant transformation. This awareness has increased the demand for porokeratosis treatments. However, the majority of awareness is currently in developed nations, but the market and awareness are rapidly expanding in developing nations as a result of the improved global dissemination of knowledge.

Side Effects Reported During Therapy

Laser treatment side effects include mild erythema, slight hyperpigmentation, and contemporary edema. According to dermentz.org, no treatment has proven to be effective over the long term, which increases patients' reluctance to undergo treatment. In addition, the high cost of treatment and people's lack of knowledge about skin treatments are other factors that inhibit the growth of porokeratosis treatment.

Laser Therapy to be the Fastest-Growing Market

Porokeratosis has become increasingly treated with laser therapy. The physician destroys the area of the skin with a laser device, allowing new skin to grow in its place. According to an article by Amarateedha Prak LeCourt, patients with various types of porokeratosis who underwent laser therapy experienced positive outcomes. One patient with linear porokeratosis, for instance, exhibited improvement when 585 nm flashlamp-pumped pulsed eye laser was administered. Another individual with DSAP responded positively to laser therapy. As laser therapy is risk-free and has no associated downtime or morbidity with pigment or textural changes, its adoption could contribute to the expansion of porokeratosis treatment.

Hospitals to Remain Dominant Segment Among the Market by End User

Hospitals represent a significant market opportunity for porokeratosis treatment. Hospitals are prominent centers for the diagnosis and treatment of porokeratosis, and they provide a comprehensive array of services, including diagnostic testing, medical and surgical treatment, and follow-up care. This can lead to increased revenue opportunities for hospitals. Utilizing the most recent technologies and developments in porokeratosis treatment, hospitals can improve patient outcomes and attract more patients. Therefore, hospitals are well-positioned to capitalize on the growing demand for effective porokeratosis treatments.

North America Remains as the Global Leader

The growth of the porokeratosis treatment market in North America is influenced by factors such as the condition's rising prevalence, rising awareness among healthcare professionals and patients, and the availability of novel treatments and therapies. The market is anticipated to be dominated by North America due to the increasing prevalence of DSAP and the number of renal transplants. According to sciencedirect.com, the incidence of porokeratosis has increased alongside the number of kidney transplant patients.

According to niddk.nih.gov, more than 661,000 Americans have kidney failure and more than 468,000 patients are on dialysis, which may impact porokeratosis cases as 10% of patients with kidney problems have the disease. Asia's contribution to the growth of the market is influenced by the expansion of healthcare infrastructure and expenditures. In addition, Japan's aging population has led to an increase in cases of the disease in the country. In Asia, DSAP and Mibelli are the most prevalent types of porokerarosis.

People's lack of knowledge about the treatment is the cause of the increase in cases; therefore, the government should take steps to help people in rural areas gain knowledge about the treatment, which could lead to a rise in treatment adoption. Europe is in second place in the porokeratosis market due to the fact that rising incidences and innovations by researchers and manufacturers are driving market expansion. Increasing participation by manufacturers in the treatment of porokeratosis may stimulate market growth.

Investment in R&D to Enhance Market Share

The producers of porokeratosis treatments employ a variety of expansion strategies to increase their market share in the global protein markets. According to the increased funding for the treatment of porokeratosis, key players are actively investing in more effective and superior treatments for porokeratosis. Key players are investing in the development and introduction of a superior and cost-effective product for the porokeratosis treatment market, particularly in developing nations where aesthetic spending is still relatively low. With an increase in funding for porokeratosis treatment and the subsequent rise in product launches, there is intense competition among the major players.

Market leaders include: Coherent Inc., Alma Lasers, Almirall, Allergan, Pfizer, Lumenis, Coty Inc., Cutera, Bioness Inc., Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp.

The FDA approved Almirall's new topical treatment for actinic keratosis, tirbanibulin, in December 2020. Tirbanibulin is a novel microtubule that must be administered once every five days. In one of the largest Phase III clinical study programs for Actinic Keratosis lesions, tirbanibulin demonstrated efficacy in 57 days on the face and scalp of a large number of patients. In January 2021, Hologic, a global leader in women's health, announced the acquisition of Biotheranostics, Inc. This company is in the commercialization phase and offers molecular diagnostic tests for breast and metastatic cancers. The goal of the acquisition is to leverage commercial capabilities, accelerate growth, provide more personalized treatment, and improve clinical outcomes for women.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Porokeratosis Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Porokeratosis Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Disseminated superficial actinic porokeratosis
  • Disseminated superficial porokeratosis
  • Surface treatment porokeratosis of mibelli
  • Injectable linear porokeratosis
  • Eruptive disseminated porokeratosis
  • Porokeratosis plantaris palmaris et disseminata
  • Punctate porokeratosis
  • Porokeratosis ptychotropica
  • Penoscrotal porokeratosis
  • Follicular porokeratosis

Diagnosis

  • Biopsy
  • Differential diagnosis
  • Squamous cell carcinoma
  • Lichenoid keratosis
  • Epidermal nevus
  • Others

Treatment

  • Topical therapies
  • Topical 5-fluorouracil
  • Topical imiquimod
  • Topical retinoids
  • Topical vitamin D analogs
  • Combination therapy
  • Systemic therapy
  • Oral retinoids
  • Physical interventions
  • Cryotherapy
  • electrodesiccation and curettage
  • surgical excision
  • dermabrasion
  • Laser Therapy
  • Carbon dioxide lasers
  • Q-switched ruby laser
  • Nd:YAG laser
  • Pulsed dye laser therapy

End-user

  • Hospitals
  • Clinics
  • Pharmacies and drug stores
  • Diagnostic Centers
  • Research and academic institutes
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Porokeratosis Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Porokeratosis Treatment market?
  • Which is the largest regional market for Porokeratosis Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Porokeratosis Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Porokeratosis Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Porokeratosis Treatment Market
  • 2.2. Global Porokeratosis Treatment Market, By Type, 2022 (US$ Million)
  • 2.3. Global Porokeratosis Treatment Market, By Diagnosis, 2022 (US$ Million)
  • 2.4. Global Porokeratosis Treatment Market, By Treatment, 2022 (US$ Million)
  • 2.5. Global Porokeratosis Treatment Market, By End-user, 2022 (US$ Million)
  • 2.6. Global Porokeratosis Treatment Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Porokeratosis Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Porokeratosis Treatment Market Vendors
  • 3.2. Strategies Adopted by Porokeratosis Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Porokeratosis Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Porokeratosis Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Disseminated superficial actinic porokeratosis
    • 5.3.2. Disseminated superficial porokeratosis
    • 5.3.3. Surface treatment porokeratosis of mibelli
    • 5.3.4. Injectable linear porokeratosis
    • 5.3.5. Eruptive disseminated porokeratosis
    • 5.3.6. Porokeratosis plantaris palmaris et disseminata
    • 5.3.7. Punctate porokeratosis
    • 5.3.8. Porokeratosis ptychotropica
    • 5.3.9. Penoscrotal porokeratosis
    • 5.3.10. Follicular porokeratosis

6. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Biopsy
    • 6.3.2. Differential diagnosis
      • 6.3.2.1. Squamous cell carcinoma
      • 6.3.2.2. Lichenoid keratosis
      • 6.3.2.3. Epidermal nevus
    • 6.3.3. Others

7. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Topical therapies
      • 7.3.1.1. Topical 5-fluorouracil
      • 7.3.1.2. Topical imiquimod
      • 7.3.1.3. Topical retinoids
      • 7.3.1.4. Topical vitamin D analogs
      • 7.3.1.5. Combination therapy
    • 7.3.2. Systemic therapy
      • 7.3.2.1. Oral retinoids
    • 7.3.3. Physical interventions
      • 7.3.3.1. Cryotherapy
      • 7.3.3.2. electrodesiccation and curettage
      • 7.3.3.3. surgical excision
      • 7.3.3.4. dermabrasion
    • 7.3.4. Laser Therapy
      • 7.3.4.1. Carbon dioxide lasers
      • 7.3.4.2. Q-switched ruby laser
      • 7.3.4.3. Nd:YAG laser
      • 7.3.4.4. Pulsed dye laser therapy

8. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Pharmacies and drug stores
    • 8.3.4. Diagnostic Centers
    • 8.3.5. Research and academic institutes
    • 8.3.6. Others

9. North America Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 9.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 9.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 9.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 9.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 9.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 9.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 9.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 9.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 9.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 9.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

10. UK and European Union Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 10.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 10.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 10.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 10.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.4.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.4.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.4.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.5.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.5.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.5.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.6.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.6.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.6.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

11. Asia Pacific Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 11.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 11.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 11.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 11.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.4.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.4.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.4.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.5.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.5.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.5.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.6.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.6.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.6.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

12. Latin America Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 12.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 12.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 12.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 12.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 12.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 12.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 12.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 12.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 12.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 12.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

13. Middle East and Africa Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 13.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 13.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 13.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 13.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 13.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 13.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 13.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 13.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 13.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 13.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 13.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 13.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 13.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Coherent Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Alma Lasers
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Almirall
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Allergan
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Pfizer
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Lumenis
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Coty Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Cutera
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Bioness Inc.
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Biogen
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. PhotoMedex Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Valeant Pharmaceuticals
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Hologic Inc.
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives
  • 14.14. IPG Photonics Corporation
    • 14.14.1. Company Overview
    • 14.14.2. Financial Performance
    • 14.14.3. Product Portfolio
    • 14.14.4. Strategic Initiatives
  • 14.15. IRIDEX Corp.
    • 14.15.1. Company Overview
    • 14.15.2. Financial Performance
    • 14.15.3. Product Portfolio
    • 14.15.4. Strategic Initiatives
  • 14.16. Others
    • 14.16.1. Company Overview
    • 14.16.2. Financial Performance
    • 14.16.3. Product Portfolio
    • 14.16.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 3 Global Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 4 Global Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 5 Global Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 6 Global Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 7 Global Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 8 Global Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 9 Global Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 10 North America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 11 North America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 12 North America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 13 North America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 14 North America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 15 North America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 16 North America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 17 North America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 18 North America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 19 U.S. Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 20 U.S. Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 21 U.S. Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 22 U.S. Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 23 U.S. Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 24 U.S. Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 25 U.S. Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 26 U.S. Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 27 U.S. Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 28 Canada Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 29 Canada Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 30 Canada Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 31 Canada Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 32 Canada Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 33 Canada Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 34 Canada Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 35 Canada Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 36 Canada Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 37 Rest of North America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Rest of North America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 39 Rest of North America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 40 Rest of North America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 41 Rest of North America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 42 Rest of North America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 43 Rest of North America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 44 Rest of North America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 45 Rest of North America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 46 UK and European Union Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 47 UK and European Union Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 48 UK and European Union Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 49 UK and European Union Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 50 UK and European Union Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 51 UK and European Union Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 52 UK and European Union Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 53 UK and European Union Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 54 UK and European Union Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 55 UK Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 56 UK Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 57 UK Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 58 UK Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 59 UK Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 60 UK Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 61 UK Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 62 UK Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 63 UK Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 64 Germany Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 65 Germany Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 66 Germany Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 67 Germany Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 68 Germany Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 69 Germany Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 70 Germany Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 71 Germany Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 72 Germany Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 73 Spain Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 74 Spain Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 75 Spain Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 76 Spain Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 77 Spain Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 78 Spain Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 79 Spain Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 80 Spain Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 81 Spain Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 82 Italy Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 83 Italy Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 84 Italy Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 85 Italy Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 86 Italy Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 87 Italy Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 88 Italy Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 89 Italy Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 90 Italy Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 91 France Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 92 France Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 93 France Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 94 France Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 95 France Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 96 France Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 97 France Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 98 France Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 99 France Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 100 Rest of Europe Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 101 Rest of Europe Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 102 Rest of Europe Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 103 Rest of Europe Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 104 Rest of Europe Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 105 Rest of Europe Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 106 Rest of Europe Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 107 Rest of Europe Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 108 Rest of Europe Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 109 Asia Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 110 Asia Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 111 Asia Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 112 Asia Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 113 Asia Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 114 Asia Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 115 Asia Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 116 Asia Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 117 Asia Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 118 China Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 119 China Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 120 China Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 121 China Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 122 China Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 123 China Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 124 China Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 125 China Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 126 China Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 127 Japan Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 128 Japan Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 129 Japan Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 130 Japan Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 131 Japan Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 132 Japan Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 133 Japan Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 134 Japan Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 135 Japan Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 136 India Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 137 India Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 138 India Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 139 India Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 140 India Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 141 India Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 142 India Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 143 India Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 144 India Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 145 Australia Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 146 Australia Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 147 Australia Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 148 Australia Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 149 Australia Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 150 Australia Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 151 Australia Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 152 Australia Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 153 Australia Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 154 South Korea Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 155 South Korea Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 156 South Korea Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 157 South Korea Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 158 South Korea Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 159 South Korea Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 160 South Korea Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 161 South Korea Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 162 South Korea Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 163 Latin America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 164 Latin America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 165 Latin America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 166 Latin America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 167 Latin America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 168 Latin America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 169 Latin America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 170 Latin America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 171 Latin America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 172 Brazil Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 173 Brazil Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 174 Brazil Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 175 Brazil Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 176 Brazil Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 177 Brazil Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 178 Brazil Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 179 Brazil Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 180 Brazil Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 181 Mexico Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 182 Mexico Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 183 Mexico Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 184 Mexico Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 185 Mexico Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 186 Mexico Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 187 Mexico Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 188 Mexico Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 189 Mexico Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 190 Rest of Latin America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 191 Rest of Latin America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 192 Rest of Latin America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 193 Rest of Latin America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 194 Rest of Latin America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 195 Rest of Latin America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 196 Rest of Latin America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 197 Rest of Latin America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 198 Rest of Latin America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 199 Middle East and Africa Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 200 Middle East and Africa Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 201 Middle East and Africa Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 202 Middle East and Africa Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 203 Middle East and Africa Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 204 Middle East and Africa Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 205 Middle East and Africa Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 206 Middle East and Africa Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 207 Middle East and Africa Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 208 GCC Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 209 GCC Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 210 GCC Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 211 GCC Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 212 GCC Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 213 GCC Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 214 GCC Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 215 GCC Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 216 GCC Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 217 Africa Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 218 Africa Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 219 Africa Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 220 Africa Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 221 Africa Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 222 Africa Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 223 Africa Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 224 Africa Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 225 Africa Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 226 Rest of Middle East and Africa Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 227 Rest of Middle East and Africa Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 228 Rest of Middle East and Africa Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 229 Rest of Middle East and Africa Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 230 Rest of Middle East and Africa Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 231 Rest of Middle East and Africa Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 232 Rest of Middle East and Africa Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 233 Rest of Middle East and Africa Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 234 Rest of Middle East and Africa Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Porokeratosis Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Porokeratosis Treatment Market: Quality Assurance
  • FIG. 5 Global Porokeratosis Treatment Market, By Type, 2022
  • FIG. 6 Global Porokeratosis Treatment Market, By Diagnosis, 2022
  • FIG. 7 Global Porokeratosis Treatment Market, By Treatment, 2022
  • FIG. 8 Global Porokeratosis Treatment Market, By End-user, 2022
  • FIG. 9 Global Porokeratosis Treatment Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global Porokeratosis Treatment Market, 2022
  • FIG. 11 Market Positioning of Key Porokeratosis Treatment Market Players, 2022
  • FIG. 12 Global Porokeratosis Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global Porokeratosis Treatment Market, By Type, 2022 Vs 2031, %
  • FIG. 14 Global Porokeratosis Treatment Market, By Diagnosis, 2022 Vs 2031, %
  • FIG. 15 Global Porokeratosis Treatment Market, By Treatment, 2022 Vs 2031, %
  • FIG. 16 Global Porokeratosis Treatment Market, By End-user, 2022 Vs 2031, %
  • FIG. 17 U.S. Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 UK Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 France Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 China Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 India Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa Porokeratosis Treatment Market (US$ Million), 2021 - 2031